5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Nitrates Therapy
Nitrates therapy, a medical approach leveraging compounds containing nitrate ions, holds significance in the field of cardiovascular medicine. Commonly used to manage conditions like angina, nitrates work by dilating blood vessels, improving blood flow, and subsequently reducing the heart's workload. Nitroglycerin, a well-known nitrate, is often employed for its rapid vasodilatory effects, providing relief during angina attacks. Beyond angina, nitrates have demonstrated efficacy in treating congestive heart failure and acute myocardial infarction. However, their use requires careful consideration, as prolonged or excessive use may lead to tolerance development. The nuanced application of nitrates in cardiovascular therapy showcases their versatility in addressing various cardiac conditions, making them a valuable tool in the pursuit of cardiovascular health.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain